High dose antipsychotic users at increased risk of breast cancer Aditi20 Jan 2023 10:30 AM ISTChina: According to a research paper published in Frontiers in Oncology, researchers have concluded that those exposed to antipsychotics at higher...
Proton pump inhibitor use linked to lower risk for female cancers Dr. Shravani Dali19 Jan 2023 8:00 PM ISTProton pump inhibitor use linked to lower risk for female cancers suggests a recent study published in the Cancers.Firm conclusions about whether...
Alkem launches novel breast cancer treatment drug Palbociclib under brand name Palbo Dr. Nandita Mohan18 Jan 2023 11:15 AM ISTPalbo comes in capsule form in multiple dose strengths with varied pricing ranges, including 125mg at INR 6125/- for 21 capsules, 100mg at Rs. 6062/-,...
Dr Reddy's Labs acquires trademark rights of breast cancer drug from Pfizer Ruchika Sharma16 Jan 2023 11:00 AM ISTThe in-house product will be retailed in the Indian market at a reduction of 85% from the current MRP to increase affordability and access to...
Sun Pharma arm launches breast cancer drug Palbociclib in India Ruchika Sharma11 Jan 2023 11:26 AM ISTMumbai: Sun Pharmaceutical Industries Limited toay announced that one of its wholly-owned subsidiaries has launched a novel anti-cancer drug,...
Medical Bulletin 9/January/2022 Isra Zaman9 Jan 2023 2:00 PM ISTHere are the top medical news for the day:Poor treatment by others may push sensitive people later to self harm: StudyNSSI behaviors include cutting...
Study finds B-cells can help predict HER2-positive breast cancer treatment response Isra Zaman9 Jan 2023 9:45 AM ISTUnderstanding why cancers respond, or don't respond, to therapy is crucial to effective and personalized treatment. In HER2-positive breast cancer,...
Medical Bulletin 6/January/2022 Isra Zaman6 Jan 2023 5:46 PM ISTHere are the top medical news for the day:Antibiotic residues in wastewater may be a threat to human health: StudyBacteria that become resistant to...
EMA validates marketing authorization application for Trodelvy for Pre-treated HR+/HER2- Metastatic Breast Cancer: Gilead Sciences Ruchika Sharma5 Jan 2023 4:30 PM ISTTrodelvy (sacituzumab govitecan-hziy) is a first-in-class Trop-2 directed antibody-drug conjugate.
Targeted therapy for children with high-risk Hodgkin lymphoma reduces relapse rates, shows trial Dr. Kamal Kant Kohli2 Jan 2023 9:45 AM ISTA targeted therapy for children with high-risk Hodgkin lymphoma (HL) was shown to significantly reduce relapse rates when tested in a large...
Metformin, promising adjuvant therapy for breast cancer treatment in obese postmenopausal women Dr Kartikeya Kohli27 Dec 2022 11:00 AM ISTEgypt: Metformin could be a safe and promising adjuvant therapy to letrozole in overweight/obese postmenopausal women with breast cancer, a recent...
USFDA nod to Alembic Pharma breast cancer injection Fulvestrant Ruchika Sharma26 Dec 2022 1:15 PM ISTFulvestrant Injection is an estrogen receptor antagonist indicated for the treatment of breast cancer.
